Quantifying Allodynia in Patients Suffering From Unilateral Neuropathic Pain Using Von Frey Monofilaments

ObjectivesThe aim of this study is to investigate whether quantitative sensory testing with Von Frey monofilaments (VFMs) can be used for the quantification of allodynia in patients with chronic neuropathic pain, and how the pain threshold of affected skin differs from healthy skin. MethodsUsing VFMs, we aimed to determine the pain threshold in 22 patients suffering from allodynia as a consequence of a chronic unilateral neuropathic pain syndrome. We performed quantitative sensory testing according to the Method of Limits protocol. We used the patient's own contralateral side and 5 healthy control participants to obtain reference values. ResultsOn the affected side, we found in 20 out of 22 patients that the pain threshold could be determined with the monofilaments. On average, these 20 patients indicated pain upon the application of monofilament with logarithmic nr. 4.56, whereas no pain threshold could be determined on the contralateral, unaffected side, and in the healthy control participants for any monofilament. DiscussionWe showed that although etiology and pathophysiology of allodynia vary individually, with VFMs the clinical symptom allodynia can be quantified in a simple and practical fashion in almost all patients.

[1]  B. Perkins,et al.  Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic. , 2002, Diabetes research and clinical practice.

[2]  J. van Egmond,et al.  Elevated detection thresholds for mechanical stimuli in chronic pain patients: support for a central mechanism. , 2000, Archives of physical medicine and rehabilitation.

[3]  L. Wilkins.  Quantitative sensory testing , 1993, Neurology.

[4]  J. Bell-Krotoski,et al.  The repeatability of testing with Semmes-Weinstein monofilaments. , 1987, The Journal of hand surgery.

[5]  R. Meyer,et al.  Secondary hyperalgesia to punctate mechanical stimuli. Central sensitization to A-fibre nociceptor input. , 1999, Brain : a journal of neurology.

[6]  C. Woolf,et al.  Neuropathic pain: aetiology, symptoms, mechanisms, and management , 1999, The Lancet.

[7]  A. Rice,et al.  Mechanisms of neuropathic pain. , 2001, British journal of anaesthesia.

[8]  Lars Arendt-Nielsen,et al.  Methods for induction and assessment of pain in humans with clinical and pharmacological examples , 2001 .

[9]  A. Basbaum,et al.  Spinal cannabinoids are anti-allodynic in rats with persistent inflammation , 1999, Pain.

[10]  M. Koltzenburg.  Painful neuropathies. , 1998, Current opinion in neurology.

[11]  D. Price,et al.  Psychophysical observations on patients with neuropathic pain relieved by a sympathetic block , 1989, Pain.

[12]  M. Rowbotham,et al.  A multicenter, double-blind, randomized, placebo-controlled crossover evaluation of a short course of 4030W92 in patients with chronic neuropathic pain. , 2002, The journal of pain : official journal of the American Pain Society.

[13]  A. Sollevi,et al.  Systemic Adenosine Infusion Alleviates Spontaneous and Stimulus Evoked Pain in Patients with Peripheral Neuropathic Pain , 1995, Anesthesia and analgesia.

[14]  J A Bell-Krotoski,et al.  Threshold detection and Semmes-Weinstein monofilaments. , 1995, Journal of hand therapy : official journal of the American Society of Hand Therapists.

[15]  J. Hardy.  An Evidence-Based Resource for Pain , 1998, BMJ.

[16]  A. Sollevi,et al.  Dose-dependent effects of morphine on experimentally induced cutaneous pain in healthy volunteers , 2005, Pain.

[17]  Z. Bajwa,et al.  Diagnosis and treatment of neuropathic pain. , 2003, Journal of pain and symptom management.

[18]  L. Arendt-Nielsen,et al.  The relationship between sensory thresholds and mechanical hyperalgesia in nerve injury , 1998, Pain.

[19]  W. S. Waring,et al.  ANTICONVULSANT DRUGS. , 1963, Progress in medicinal chemistry.

[20]  E. Torebjörk,et al.  Psychophysical evidence of nociceptor sensitization in vulvar vestibulitis syndrome , 2001, Pain.

[21]  R. Dotson,et al.  Clinical neurophysiology laboratory tests to assess the nociceptive system in humans. , 1997, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[22]  R. Meyer,et al.  Mechanisms of Neuropathic Pain , 2006, Neuron.

[23]  J. Ochoa,et al.  Quantitative somatosensory thermotest. A key method for functional evaluation of small calibre afferent channels. , 1992, Brain : a journal of neurology.

[24]  P. Wiffen,et al.  Antidepressants for neuropathic pain. , 2007, The Cochrane database of systematic reviews.

[25]  T. Nurmikko.  Pathophysiology and treatment of neuropathic pain , 1993 .

[26]  A. Stubhaug,et al.  Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo , 1997, PAIN.

[27]  P J Dyck,et al.  Quantitative Sensory Testing: Methodology, Applications, and Future Directions , 1994, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[28]  Ulf Lindblom,et al.  CLASSIFICATION OF CHRONIC PAIN , 2004 .

[29]  D. Simone,et al.  Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms , 2001, Pain.

[30]  T. Yaksh,et al.  Concentration–effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain , 2001, Pain.

[31]  Frank Birklein,et al.  Brain processing during mechanical hyperalgesia in complex regional pain syndrome: a functional MRI study , 2005, Pain.

[32]  R. LaMotte,et al.  Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms. , 1991, Journal of neurophysiology.

[33]  J. Loeser,et al.  Bonica's Management of Pain , 2001 .

[34]  H. Flor,et al.  Activation of naloxone-sensitive and -insensitive inhibitory systems in a human pain model. , 2005, The journal of pain : official journal of the American Pain Society.

[35]  B. Zinman,et al.  Simple screening tests for peripheral neuropathy in the diabetes clinic. , 2000, Diabetes care.

[36]  M. Wallace,et al.  The Effect of Chronic Oral Desipramine on Capsaicin-Induced Allodynia and Hyperalgesia: A Double-Blinded, Placebo-Controlled, Crossover Study , 2002, Anesthesia and analgesia.

[37]  J. Brooks,et al.  A role for the brainstem in central sensitisation in humans. Evidence from functional magnetic resonance imaging , 2005, Pain.